Navigation Links
Sigma-Aldrich Signs Agreement With SouthWest NanoTechnologies to Distribute SWeNT(R) Single-Wall Carbon Nanotubes

ST. LOUIS, Dec. 3 /PRNewswire-FirstCall/ -- Sigma-Aldrich (Nasdaq: SIAL) and SouthWest NanoTechnologies Inc. (SWeNT), a leading producer of single-wall carbon nanotubes, announced today that they have signed an agreement under which Sigma-Aldrich will distribute SWeNT's single-wall carbon nanotubes to the research and development community.

Under the terms of the agreement, Sigma-Aldrich will exclusively distribute research quantities of SWeNT(R) CG 100, SWeNT(R) SG 65 and SWeNT(R) SG 76 single-wall nanotubes globally through its Aldrich(R) division ( SWeNT will continue to work closely with industry partners to deliver commercial quantities of the materials and focus on commercial application development and large-scale production.

Single-wall carbon nanotubes consist of a hollow cylinder of carbon with a diameter equal to approximately one nanometer -- a billionth of a meter. Due to their unusual structure, single-wall nanotubes exhibit extraordinary optical and electronic properties, tremendous strength and flexibility, and high thermal and chemical stability. These remarkable properties make them suitable for a wide range of applications in the automotive, aeronautics, electronics, displays, energy and healthcare markets.

"There are significant global market opportunities for single-wall carbon nanotubes, and Sigma-Aldrich has a world-class distribution network. This agreement will provide the best possible products and service to the research and development community, which is incorporating SWeNT carbon nanotubes into innovative, emerging technologies," said SWeNT CEO David Arthur. "In our role as a leading producer of high-quality single-wall nanotubes, we are committed to being an innovative partner in Sigma-Aldrich's continued development and creative applications. This agreement is key to reaching that goal."

Ilya Koltover, business development manager, Aldrich Chemistry and Materials Science, added: "Progress in nanotechnology research depends on a reliable supply of consistently high-quality nanomaterials, supported by thorough characterization and technical information. This is especially true for single wall carbon nanotubes, and we are pleased to work with SWeNT, who is committed to the goal of providing such supply. This partnership will help researchers and accelerate nanotechnology innovation around the world."

For more information about the single-wall carbon nanotubes, visit

About Sigma-Aldrich: Sigma-Aldrich is a leading Life Science and High Technology company. Its biochemical and organic chemical products and kits are used in scientific and genomic research, biotechnology, pharmaceutical development, the diagnosis of disease and as key components in pharmaceutical and other high technology manufacturing. Sigma-Aldrich has customers in life science companies, university and government institutions, hospitals, and in industry. Over one million scientists and technologists use our products. The Company operates in 36 countries and has 8,000 employees providing excellent service worldwide. Sigma-Aldrich is committed to Accelerating Customer Success through Leadership in Life Science, High Technology and Service. For more information about Sigma-Aldrich, please visit its award-winning website at

About SouthWest NanoTechnologies: SWeNT produces three lines of carbon nanotube products using the patented CoMoCAT(R) catalytic method, widely recognized for its quality and scalability. The Company was founded in 2001 to commercialize nanotube technology developed at the University of Oklahoma by Daniel Resasco, a professor of chemical engineering and world-renowned expert in the fields of single-wall carbon nanotubes and catalysis. In June 2008, SWeNT moved to its new $3.9 million, 18,000-square-foot manufacturing facility in Norman. With approximately 10,000 square feet of 32-foot high-bay production space, SWeNT can produce at least 100 times more product than at its previous pilot plant location. For more information about SWeNT, visit

Cautionary Statement: This release contains forward-looking statements relating to future performance, goals, strategic actions and initiatives and similar intentions and beliefs and other statements regarding the Companies' expectations, goals, beliefs, intentions and the like, which involve assumptions regarding the Companies' operations and conditions in the markets the Companies serve. The Companies do not undertake any obligation to update these forward-looking statements.

Sigma-Aldrich and Aldrich are trademarks of Sigma-Aldrich Biotechnology LP and Sigma-Aldrich Co.

SWeNT(R) and CoMoCAT(R) are registered trademarks of SouthWest NanoTechnologies Inc.

SOURCE Sigma-Aldrich
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Sigma-Aldrich (Nasdaq: SIAL) Declares Quarterly Dividend
2. Sigma-Aldrich and Lab Manager Magazine Present Webinar On Laboratory Environmental, Health and Safety Compliance Strategies
3. Sigma-Aldrich Expansion in Republic of China to Support SAFC Growth
4. Sigma-Aldrich and Ingenuity Systems Announce Partnership to Create E-Commerce Search Solution Based on Biological Knowledge
5. Sigma-Aldrich to Present at the UBS 2007 Global Life Sciences Conference on September 25, 2007
6. Sigma-Aldrich Names Patrick Sullivan New VP of Research and Development for Research Biotech
7. Sigma-Aldrich and the Universite de Montreal Establish Collaboration for RNA Interference Studies
8. Sigma-Aldrich Corporations 3rd Quarter 2007 Earnings Conference Call
9. Sigma-Aldrich Introduces N-TER Nanoparticle siRNA Transfection System for Delivery of siRNA Into Difficult-to-Transfect Cell Types
10. Sigma-Aldrich (Nasdaq: SIAL) Q3 2007 Sales Increase 14.0%, Yielding Diluted EPS of $.54.
11. Sigma-Aldrich and Oxford BioMedica Win Key Ruling in Open Biosystems Patent Infringement Dispute
Post Your Comments:
(Date:11/25/2015)... November 26, 2015 ... Market 2016 - 2020 report analyzes that automating ... and quality in long-term samples, minimizing manual errors, ... Automation minimizes manual errors such as mislabeling or ... Further, it plays a vital role in blood ...
(Date:11/25/2015)... -- Neurocrine Biosciences, Inc. (Nasdaq: NBIX ) announced today ... Neurocrine Biosciences, will be presenting at the 27th Annual ... . .   Listeners ... prior to the presentation to download or install any ... available on the website approximately one hour after the ...
(Date:11/25/2015)... ... November 25, 2015 , ... ... were featured on AngelList early in their initial angel funding process. Now, they ... for individuals looking to make early stage investments in the microbiome space. ...
(Date:11/24/2015)... , Nov. 24, 2015 /CNW/ - iCo Therapeutics ("iCo" ... reported financial results for the quarter ended September ... in Canadian dollars and presented under International Financial ... States ," said Andrew Rae , ... regarding iCo-008 are not only value enriching for ...
Breaking Biology Technology:
(Date:11/18/2015)... 18, 2015  As new scientific discoveries deepen our ... other healthcare providers face challenges in better using that ... In addition, as more children continue to survive pediatric ... and old age. John M. Maris, M.D ... of Philadelphia (CHOP) . --> John ...
(Date:11/17/2015)... 17, 2015  Vigilant Solutions announces today that Mr. ... of Directors. --> --> ... from the partnership at TPG Capital, one of the ... $140 Billion in revenue.  He founded and led TPG,s ... TPG companies, from 1997 to 2013.  In his first ...
(Date:11/12/2015)... 2015  Arxspan has entered into an agreement ... for use of its ArxLab cloud-based suite of ... partnership will support the institute,s efforts to electronically ... information internally and with external collaborators. The ArxLab ... the Institute,s electronic laboratory notebook, compound and assay ...
Breaking Biology News(10 mins):